Certara, Inc. operates as a bio-technology company. The Company focuses on accelerating medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Certara serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-08-06)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Certara (CERT US)

Current Report (Form 8-K | Period ending 2024-08-06)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-07-17)

Current Report (Form 8-K | Period ending 2024-07-09)

Current Report (Form 8-K | Period ending 2024-06-26)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)